Boston Therapeutics Inc (OTCQB:BTHE)

0.08
Delayed Data
As of May 25
 -0.008 / -9.09%
Today’s Change
0.03
Today|||52-Week Range
0.12
+100.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues199.6K98.9K98.9K29.4K
 
 
 
 
 
Cost of Goods Sold104.9K169.4K23.8K47.0K
 
 
 
 
 
Depreciation And Amortization70.9K71.0K70.4K67.0K
 
 
 
 
 
 
Operating ExpensesGross Income23.8K-141.5K4.7K-84.7K
 
 
 
 
 
General Expenses4.7M2.0M1.3M1.2M
 
 
 
 
 
Research And Development1.4M352.8K83.8K113.4K
 
 
 
 
 
Total Operating Expenses4.9M2.2M1.4M1.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.7M-2.1M-1.3M-1.3M
 
 
 
 
 
Extraordinary Credit0.00421.3K0.001.5M
 
 
 
Extraordinary Charge0.00-146.0K-124.5K-81.5K
 
 
 
 
Interest Expense On Debt20.0K659.6K1.9M1.8M
 
 
 
 
 
Other Expenses-5.6K-4.3K-402.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-2.5M-3.7M-1.6M
 
 
 
 
 
Income Taxes0.000.00-4.0K0.00
 
 
Net Income-4.7M-2.5M-3.7M-1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.2M39.1M43.5M51.5M
 
 
 
 
 
Shares To Calculate EPS Diluted38.2M39.1M43.5M51.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.06-$0.09-$0.03
 
 
 
 
 
EPS Diluted-$0.12-$0.06-$0.09-$0.03